Novo Nordisk A/S (NVO)

Trade NVO now with
2/5/2019 2:36:40 AM Novo Nordisk Files Annual Report With SEC
2/1/2019 1:34:18 AM Novo Nordisk FY EPS Increase To 4% To DKK 15.93
12/17/2018 2:31:47 AM Forbion Portfolio Company Staten Biotechnology Enters Into Collaboration With Novo Nordisk
11/1/2018 2:35:24 AM Novo Nordisk 9-month EPS Increase 3% To DKK 12.40
10/26/2018 9:05:08 AM Novo Nordisk Announces Headline Results From PIONEER 8 Phase 3a Trial
10/23/2018 12:02:18 PM Pacton Acquires Calidus Conglomerate Gold Rights
10/15/2018 6:13:20 AM Novo Nordisk Appoints Ludovic Helfgott As EVP Of Biopharm, Effective Apr 3
10/1/2018 8:01:16 AM Novo Nordisk Canada: Health Canada Approves TRESIBA For Children With Type 1 Diabetes
10/1/2018 7:14:35 AM Asterias Biotherapeutics Enters Into Two New Agreements With Affiliate Of Novo Nordisk
9/20/2018 8:19:59 AM Novo Nordisk Announces Headline Results From PIONEER 10 Phase 3a Trial
9/12/2018 6:03:22 AM EyePoint Pharmaceuticals Q4 Net Loss Widens To $53.2 Mln Or $1.15/shr From $18.5 Mln Or $0.52/shr Last Year